A new dual-action drug for high cholesterol


  • Wellness Premium
  • Thursday, 28 Sep 2017

Early stage of atherosclerosis when fatty streak forms in the artery, leading to lipid plaques forming within the artery and arterial wall thickening. — 123rf.com

MSD Malaysia recently announced the approval of its new drug to lower cholesterol in Malaysia.

The drug (ezetimibe and atorvastatin) has a dual mechanism of action: it treats the two main sources of cholesterol in the blood by inhibiting the absorption of cholesterol in the digestive tract (through ezetimibe) and the production of cholesterol in the liver (atorvastatin).

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Others Also Read


Vouchers